Australia's largest stock trading and investment forum Australia's #1 stock forum

CHM

0.00%

1.4¢ chimeric therapeutics limited

5 to10 bags gives a market cap of only $aud100 to $aud200...

First 616 Last

Share
Profile

Follow
dalts66

4,412 Posts.

2059

18/02/24

21:11

Post #: 72473182
Share

Originally posted by pinch2020: ↑

Always nice when none holders take time out of their busy schedules to share their wisdom.

I disagree with your assertions but let's see what father time has instore for us.

Our Phase 1B CHM0201 +VACTOSERIB data could drop at some stage.

I'm expecting CHM 2101 Basket trial to kick off in the next couple of months. This is an ENORMOUS milestone, this trial has the potential to change the whole landscape. Preclinical data demonstrated complete eradication of tumor cells and no relapse of tumor cells. First in class targeting CDH17. The Basket trial addressing Gastric cancer (5th most common), colorectal cancer (3rd most common cancer) and Neuroendocrine tumors which in recent years has had a 6.5x increase.

Safety progress in ADVENT-AML trail and CHM2101.

Periodic updates on the progression of all 4 trials we'll have in the clinic, all addressing high unmet needs.

I agree with @dalts66. The opportunity the share price is currently presenting is a rare opportunity and I can only imagine that's why you are here.

This will start to rise throughout the year and personally I see 5-10 bags by this time next year.

Expand

5 to10 bags gives a market cap of only $aud100 to $aud200 million. And as you have said there will be 4 trials hitting arms by then and several pivot data points. Thats cheap even in these market conditions.

Nothing is ever a sure thing. But there sure is huge potential here.

CHM Price at posting: 2.6¢ Sentiment: Buy Disclosure: Held
9 Upvote

0 Great analysis

Reply

Top Stories

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

What's causing the cost-of-living crisis, and how to navigate it

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint